Loading...
 

Volume 34, Issue 4, December 2023



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(1):117-20
Investigating the Role of T-bet+ B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus
Authors Information

14th Department of Internal Medicine, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

2Paediatric Immunology and Rheumatology Referral Centre, 1st Paediatric Department, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

3Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thermi, Thessaloniki, Greece

4Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, Heraklion, Greece

54th Department of Internal Medicine, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece


A Sachinidis, M Trachana, A Taparkou, G Gavriilidis, P Verginis, F Psomopoulos, C Adamichou, D Boumpas, A Garyfallos

Abstract

Background: Age-associated B cells (ABCs) constitute a B cell subset, defined as CD19+CD21-CD11c+, that expands continuously with age and accumulates strongly in individuals with autoimmune and/or infectious diseases. In humans, ABCs are principally IgD-CD27- double-negative (DN) B cells. Data from murine models of autoimmunity, implicate ABCs/DN in the development of autoimmune disorders. T-bet, a transcription factor which is highly expressed in these cells, is considered to play a major role in various aspects of autoimmunity, such as the production of autoantibodies and the formation of spontaneous germinal centres. Aims of the study: Despite the available data, the functional features of ABCs/DN and their exact role in the pathogenesis of autoimmunity remain elusive. This project focuses on the investigation of the role of ABCs/DN in the pathogenesis of systemic lupus erythematosus (SLE) in humans, as well as the effects that various pharmacological agents may have on these cells. Methods: Samples from patients with active SLE will be used to enumerate and immunophenotype - via flow cytometry - the ABCs/DN found in the peripheral blood of the patients. Transcriptomic analysis and functional assays for the cells, both before and after in vitro pharmacological treatments, will also be performed. Anticipated benefits: The results of the study are expected to allow characterization of the pathogenetic role of ABCs/DN in SLE and could probably contribute, following careful association with the clinical state of the patients, towards the discovery and validation of novel prognostic and diagnostic markers of disease.


Cite this article as: Sachinidis A, Trachana M, Taparkou A, Gavriilidis G, Verginis P, Psomopoulos F, Adamichou C, Boumpas D, Garyfallos A. Investigating the Role of T-bet+ B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus. Mediterr J Rheumatol 2023;34(1):117-20.

Article Submitted: 17 Jan 2022; Revised Form: 23 Nov 2022; Article Accepted: 5 Dec 2022; Available Online: 31 Mar 2023

https://doi.org/10.31138/mjr.34.1.117

This work is licensed under a Creative Commons Attribution 4.0 International License.

©2023 The Author(s).